TETRAPHASE PHARMACEUTICALS I
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for TETRAPHASE PHARMACEUTICALS I CALL, CUSIP 88165N904.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for TETRAPHASE PHARMACEUTICALS I CALL, CUSIP 88165N904.